Title: Cheng H et al. Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04979064 through Structure-Based Drug Design. ACS Med Chem Lett, 2012 Nov 7, 4(1):91-7.
1215799-39-5 | 5-BENZYLOXY OMEPRAZOLE | AA009D4A | MFCD09840038
13356-09-7 | HEXAKIS(2-METHYL-2-PHENYLPROPYL)DITIN | AA009DDH | MFCD08275539
1243249-99-1 | 6-Bromopyrazolo[1,5-a]pyrimidine-3-carboxamide | AA009DRF | MFCD17078895
1255147-35-3 | 4-Methyl-5-(methylsulfonyl)pyrimidin-2-amine | AA009DV2 | MFCD18064604
1246816-59-0 | Carbovir-13C,d2 | AA009E16 | MFCD28138274
13326-10-8 | Benzyl Methyl Carbonate | AA009E7X | MFCD23714704
1217200-17-3 | CloMiphene-d5 Citrate | AA009EGV | MFCD28899367
1216630-06-6 | Medetomidine-13C,d3 Hydrochloride | AA009EOR
13877-16-2 | Iron(ii) tetrafluoroborate hexahydrate | AA009EX2 | MFCD00016079
1346605-26-2 | Hesperetin-D3 | AA009F4G | MFCD22570271